>

BRAWN BIOTECH (India) Financial Analysis

530
530207 -- India Stock  

INR 27.45  3.85  16.31%

Macroaxis technical analysis interface gives you tools to check possible technical drivers of BRAWN BIOTECH LTD as well as the relationship between them. The company executives were quite successful positioning the firm resources to exploit market volatility in March 2020. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 10.03. The very high volatility is mostly attributed to the latest market swings and not very good earning reports from some ot the BRAWN BIOTECH LTD partners. The BRAWN BIOTECH LTD financial analysis interface makes it easy to digest most current publicly released information about BRAWN BIOTECH as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analyze BRAWN BIOTECH price relationship with some important fundamental indicators such as market cap and management efficiency. Please continue to Trending Equities.

BRAWN BIOTECH Note

The company had not issued any dividends in recent years.

BRAWN BIOTECH LTD Alerts

BRAWN BIOTECH LTD is not yet fully synchronised with the market data
BRAWN BIOTECH LTD appears to be very risky and stock price may revert if volatility continues

Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 82.36 M.

BRAWN BIOTECH Technical and Predictive Indicators

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module
Please continue to Trending Equities. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Company logos by clearbit